Sócio Farmácia

Principais Atividades

Ensino de 1.º, 2.º e 3.º ciclos.
Investigação científica e desenvolvimento tecnológico.
Serviços de extensão universitária:
            serviços ao exterior
            atividades complementares no domínio da formação contínua e da promoção da inovação.

Órgãos

Presidente
Rogério Paulo Pinto de Sá Gaspar

Comissão Executiva de Departamento
(em atualização)

Comissão de Departamento
A Comissão de Departamento é constituída pelos Doutores do DSF com vínculo à FFUL.

Investigação

Unidades de I&D

Instituto de Investigação do Medicamento (iMed.ULisboa)
            Grupo de Investigação:
            Farmacoepidemiologia e Sócio-Farmácia

Publicações

2019

2018

2016

  • Advinha AM, Henriques A, Guerreiro MP, Nunes C, Lopes MJ, de Oliveira-Martins S. Cross-cultural validation of the Drug Regimen Unassisted Grading Scale (DRUGS) to assess community-dwelling elderly’s ability to manage medication. European Geriatric Medicine. 2016;7(5):424–9.
  • Araújo O, Lage I, Cabrita J, Teixeira L. Development and psychometric properties of ECPICID-AVC to measure informal caregivers’ skills when caring for older stroke survivors at home. Scandinavian Journal of Caring Sciences. 2016;30(4):821–9.
  • Cabral AC, Moura-Ramos M, Caramona M, Castel-Branco M, Figueiredo I V, Fernandez-Llimos F. Developing a maastricht utrecht adherence in Hypertension Questionnaire short version: MUAH16. International Journal of Clinical Pharmacy. 2016;38(5):1339–40.
  • Cabral AC, Rotta I, Caramona M, Castel-Branco M, Figueiredo I V, Fernandez-Llimos F. Assessing the homogeneousness in the use the 8-Items Morisky Medication Adherence Scale (MMAS-8). International Journal of Clinical Pharmacy. 2016;38(2):493.
  • Cavaco AM, Pires C, Vigario M. Linguistics metrics of package leaflets: estimating effects on users’ comprehension of medicines information. International Journal of Clinical Pharmacy. 2016;38(2):506.
  • Cláudio AP, Carmo MB, Guerreiro MP, Cavaco A, Pinto V, Pinha A. Virtual Humans playing the role of patients in self-medication consultations: Perspectives of undergraduate pharmacy students. In: VISIGRAPP 2016 - Proceedings of the 11th Joint Conference on Computer Vision, Imaging and Computer Graphics Theory and Applications. 2016. p. 298–305.
  • Corvo ML, Mendo AS, Figueiredo S, Gaspar R, Larguinho M, da Silva MFC, et al. Liposomes as Delivery System of a Sn(IV) Complex for Cancer Therapy. Pharmaceutical Research. 2016 Jun;33(6):1351–8.
  • Corvo ML, Mendo AS, Figueiredo S, Gaspar R, Larguinho M, Guedes da Silva MFC, et al. Liposomes as Delivery System of a Sn(IV) Complex for Cancer Therapy. Pharmaceutical Research. 2016;33(6):1351–8.
  • Dreischulte T, Fernandez-Llimos F. Current perceptions of the term Clinical Pharmacy and its relationship to Pharmaceutical Care: a survey of members of the European Society of Clinical Pharmacy. International Journal of Clinical Pharmacy. 2016;38(6):1445–56.
  • Duarte M, Ferreira P, Soares M, Martins AP, Cavaco A. Community pharmacists’ knowledge and perceptions on risk management plans in the Southern Region of Portugal. Clinical Research and Regulatory Affairs. 2016;33(2–4):33–8.
  • Fernandez-Llimos F, Melo L, Lavrador M, Caramona M, Figueiredo I V, Castel-Branco M. Association between necessities and concerns about medication and medication adherence in Brazilian ambulatory patients. International Journal of Clinical Pharmacy. 2016;38(2):497–8.
  • Fernandez-Llimos F, Vilela F, Reis W, Patriota B, Correr C. Comparison of three scales of drugs with anticholinergic effects on Brazilian polypharmacy population. International Journal of Clinical Pharmacy. 2016;38(2):476.
  • Fernandez-Llimos F. Bradford’s law, the long tail principle, and transparency in journal impact Factor calculations. Pharmacy Practice. 2016;14(3).
  • Florindo H, Lopes J, Silva L, Corvo M, Martins M, Gaspar R. Regulatory development of Nanotechnology-based vaccines. In: Micro- and Nanotechnology in Vaccine Development. Amsterdam: Elsevier; 2016. p. 393–410.
  • Gaffney VJ, Mota-Filipe H, Pinto RA, Thiemermann C, Loureiro M, Cardoso VV, et al. Chemical and biochemical characterization and in vivo safety evaluation of pharmaceuticals in drinking water. Environmental Toxicology and Chemistry. 2016;35(11):2674–82.
  • Garcia-Cardenas V, Armour C, Benrimoj SI, Martinez-Martinez F, Rotta I, Fernandez-Llimos F. Pharmacists’ interventions on clinical asthma outcomes: A systematic review. European Respiratory Journal. 2016;47(4):1134–43.
  • Guerreiro MP, Borges A, Cavaco A. Comparison of referral criteria for minor ailments from tertiary sources: preliminary results. International Journal of Clinical Pharmacy. 2016;38(2):474–5.
  • Leonardo C, Ruiz-Moral R, Caballero F, Cavaco A, Moore P, Paula Dupuy L, et al. A Latin American, Portuguese and Spanish consensus on a core communication curriculum for undergraduate medical education. BMC Medical Education. 2016 Mar;16.
  • Martins AP, Gonçalves E, Marcelo A, Vilão S, Da Silva JA. Pharmacy medicines not subject to medical prescription in Portugal: An underused access opportunity? | Medicamentos Não Sujeitos a Receita Médica de Dispensa Exclusiva em Farmácia em Portugal: Uma Oportunidade de Acesso Sub-Aproveitada? Acta Medica Portuguesa. 2016;29(9):542–8.
  • Martins J, Rodrigues J, Martins AP, Andreozzi V, Vandewalle B, Felix J, et al. Long-term effect of the Portuguese Universal Access Program to new generation direct-acting antivirals for the treatment of Hepatitis C. Journal of Hepatology. 2016;64(2):S778–9.
  • Mendes AE, Tonin FS, Fernandez-Llimos F. Analysis of ten years of publishing in pharmacy practice. Pharmacy Practice. 2016;14(4).
  • Mograo J, Da Costa CA, Gaspar R, Florindo HF. Modulation of dendritic cells by nanotechnology-based immunotherapeutic strategies. Journal of Biomedical Nanotechnology. 2016;12(3):405–34.
  • Moital I, Carrasco J, Adegas P, Cabrita J, Martins OS. Pessoa Study- Evaluating the burden of psoriasis in Portugal from the patients’ perspective (a patient reported outcomes analysis). Value In Health. 2016 Nov;19(7):A617.
  • Morais EM, Salgado TM, Gomez IV, Duarte AM, Fernandez-Llimos F. Differences in the information about procedures after cold chain disruption provided by pharmaceutical industry to hospital and community pharmacies. European Journal of Hospital Pharmacy. 2016;23(2):96–9.
  • Nunes-da-Cunha I, Arguello B, Martinez Martinez F, Fernandez-Llimos F. A Comparison of Patient-Centered Care in Pharmacy Curricula in the United States and Europe. American Journal of Pharmaceutical Education. 2016;80(5).
  • Nunes-da-Cunha I, Fernandez-Llimos F. Systematic coding of pharmacy practice educational contents. Pharmaceutical Care Espana. 2016;18(1):28–42.
  • Pinho S, Ramalhinho I, Filipe Mota H. Antibiotic consumption in Portugal: 2010 and 2011. International Journal of Clinical Pharmacy. 2016;38(2):564.
  • Pires C, Vigário M, Cavaco A. Factors influencing subjects’ comprehension of a set of medicine package inserts. International Journal of Clinical Pharmacy. 2016;38(4):888–98.
  • Pires C, Vigário M, Cavaco A. Graphical content of medicinal package inserts: An exploratory study to evaluate potential legibility issues. Health Information and Libraries Journal. 2016;33(2):121–39.
  • Ramalhete N, Machado A, Serrano R, Gomes ET, Mota-Filipe H, Silva O. Comparative study on the in vivo antidepressant activities of the Portuguese Hypericum foliosum, Hypericum androsaemum and Hypericum perforatum medicinal plants. Industrial Crops and Products. 2016;82:29–36.
  • Ramalhinho IMPS, Magalhaes J, Pinho S, Ataide Ferreira J, Cavaco A, Mota Filipe H, et al. Urinary tract infections: outpatient antibiotic use and antimicrobial resistance in the Algarve Region. International Journal of Clinical Pharmacy. 2016;38(2):564.
  • Reis W, Lombardi N, Vilela F, Fernandez-Llimos F, Correr C. Regulatory differences among Brazilian, European and American official drug labelling. International Journal of Clinical Pharmacy. 2016;38(2):512.
  • Rodrigues J, Tato-Marinho R, Mota-Filipe H, Martins AP, Martins JC, Andreozzi V, et al. Evidence of Impressive Realworld SVR from the Portuguese Ledipasvir/Sofosbuvir and Sofosbuvir Universal Coverage Program to Eradicate (Eliminate) Hepatitis C. Journal of Hepatology. 2016;64(2):S224.
  • Sabater-Galindo M, Fernandez-Llimos F, Sabater-Hernández D, Martínez-Martínez F, Benrimoj SI. Healthcare professional-patient relationships: Systematic review of theoretical models from a community pharmacy perspective. Patient Education and Counseling. 2016;99(3):339–47.
  • Sabater-Hernandez D, Moullin JC, Hossain LN, Durks D, Franco-Trigo L, Fernandez-Llimos F, et al. Intervention mapping for developing pharmacy-based services and health programs: A theoretical approach. American Journal of Health-System Pharmacy. 2016;73(3):156–64.
  • Sabater-Hernández D, Sabater-Galindo M, Fernandez-Llimos F, Rotta I, Hossain LN, Durks D, et al. A systematic review of evidence-based community pharmacy services aimed at the prevention of cardiovascular disease. Journal of Managed Care and Specialty Pharmacy. 2016;22(6):699–713.
  • Santos PS, Viegas E, Mousinho F, Baptista T, Reichert A, Gomes AP, et al. Antiretroviral therapy and chemotherapy in patients with HIV infection and haematological disease - toxicity assessment. Haematologica. 2016 Jun;101(1):490.
  • Seidling HM, Stuetzle M, Hoppe-Tichy T, Allenet B, Bedouch P, Bonnabry P, et al. Best practice strategies to safeguard drug prescribing and drug administration: an anthology of expert views and opinions. International Journal of Clinical Pharmacy. 2016;38(2):362–73.
  • Sousa-Martins D, Sousa S, Duarte L, Monteiro M. Lutein reaches the retina following iontophoresis application. Investigative Ophthalmology & Visual Science. 2016;57(12).
  • Tato-Marinho R, Mota-Filipe H, Martins AP, Martins J, Rodrigues J, Andreozzi V, et al. Universal Access to new generation direct-acting antivirals to reduce the burden of Hepatitis C In Portugal. Journal of Hepatology. 2016;64(2):S816–7.
  • Tonin FS, Wiens A, Fernandez-Llimos F, Pontarolo R. Iloperidone in the treatment of schizophrenia: An evidence-based review of its place in therapy. Core Evidence. 2016;11:49–61.
  • Torre C, Guerreiro J, Longo P, Leufkens H, Martins AP. New Glucose Lowering Drugs (Gld) Usage in Portugal: Results of an Intensive Monitoring Study in Real-Life Conditions. Pharmacoepidemiology and Drug Safety. 2016;25(S3):193.
  • Veiga P, Velez Lapao L, Miguel Cavaco A, Pereira Guerreiro M. Reporting pharmacy staff communication for OTC medicines encounters with simulated patients. International Journal of Clinical Pharmacy. 2016;38(2):503–4.
  • Zupančič E, Peres C, Matos AI, Lopes J, Moreira JN, Gaspar RS, et al. Translational peptide-associated nanosystems: Promising role as cancer vaccines. Current Topics in Medicinal Chemistry. 2016;16(3):291–313.

Atividades de Divulgação e Extensão Universitária

Exposição Descobre a ULisboa

Contactos

Localização: Edifício H – C.3.13
Tel.: 217 946 457
Extensão interna: 14336
e-mail: rgaspar@ff.ulisboa.pt

Partilhar